Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor–Positive Breast Cancer Models with a Distinct Mechanism of Action

@article{Yu2017SelectiveAR,
  title={Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor–Positive Breast Cancer Models with a Distinct Mechanism of Action},
  author={Ziyang Yu and S. He and Dannie Wang and H. Patel and C. P. Miller and J. Brown and G. Hattersley and J. Saeh},
  journal={Clinical Cancer Research},
  year={2017},
  volume={23},
  pages={7608 - 7620}
}
  • Ziyang Yu, S. He, +5 authors J. Saeh
  • Published 2017
  • Medicine
  • Clinical Cancer Research
  • Purpose: Steroidal androgens suppress androgen receptor and estrogen receptor positive (AR/ER+) breast cancer cells and were used to treat breast cancer, eliciting favorable response. The current study evaluates the activity and efficacy of the oral selective AR modulator RAD140 in in vivo and in vitro models of AR/ER+ breast cancer. Experimental Design: A series of in vitro assays were used to determine the affinity of RAD140 to 4 nuclear receptors and evaluate its tissue-selective AR activity… CONTINUE READING
    9 Citations
    The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells
    • 1
    The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
    • 23
    • PDF
    Metabolic studies of selective androgen receptor modulators RAD140 and S-23 in horses.

    References

    SHOWING 1-10 OF 74 REFERENCES
    Targeting androgen receptor in estrogen receptor-negative breast cancer.
    • 283
    • PDF
    Targeting the Androgen Receptor in Breast Cancer
    • 73
    • PDF
    Pushing estrogen receptor around in breast cancer.
    • 26
    • PDF
    Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
    • 43
    • PDF
    Targeting the androgen receptor in prostate and breast cancer: several new agents in development.
    • 60
    • PDF
    Importance of Breast Cancer Subtype in the Development of Androgen-Receptor-Directed Therapy
    • 15
    • PDF
    Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts
    • 9